Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Our Science
Lead Drug Development
Cholesterol-Lowering Program
Brain Injury Program
Technical Glossary
Drug Development Pathway
Investors
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Corporate Announcements
Investor Presentations
Financial Reports
Share Price Information
Key Dates
Investors Glossary
Financial Reports
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Corporate Announcements
Investor Presentations
Financial Reports
Share Price Information
Key Dates
Investors Glossary
Financial Reports
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
ASX Announcements
Filter by Year:
2023
2022
2021
2020
11-Sep-2020
Corporate Presentation for ShareCafe Hidden Gems Webinar
9-Sep-2020
Nyrada Investor Webinar
8-Sep-2020
Initial Director's Interest Notice - ID
8-Sep-2020
Final Director's Interest Notice - GK
8-Sep-2020
Annual Report to 30 June 2020
8-Sep-2020
Appendix 4G and Corporate Governance Statement
31-Aug-2020
FY 2020 Appendix 4E Preliminary Financial Report
31-Aug-2020
Nyrada Board Changes
30-Jul-2020
Nyrada Global Webcast Invitation
29-Jul-2020
Nyrada A$1.0M R&D Tax Rebate & Use of Funds Annexure
Previous
1
2
3
4
5
6
7
8
Next
